학술논문

Symptomatic presentation of cervical cancer in emergency departments in California
Document Type
article
Source
Cancer Causes & Control. 32(12)
Subject
Prevention
Cervical Cancer
Clinical Research
Health Services
Cancer
4.1 Discovery and preclinical testing of markers and technologies
Detection
screening and diagnosis
California
Emergency Service
Hospital
Female
Humans
Mass Screening
Odds Ratio
Uterine Cervical Neoplasms
Cervical cancer
Emergency department
Symptomatic presentation
Socioeconomic status
Population-based
Oncology and Carcinogenesis
Public Health and Health Services
Epidemiology
Language
Abstract
PurposeThrough screening and HPV vaccination, cervical cancer can mostly be prevented or detected very early, before symptoms develop. However, cervical cancer persists, and many women are diagnosed at advanced stages. Little is known about the degree to which U.S. women may begin their diagnostic workup for cervical cancer in Emergency Departments (ED). We sought to quantify the proportion of women presenting symptomatically in the ED prior to their diagnosis with cervical cancer and to describe their characteristics and outcomes.MethodsWe identified women diagnosed from 2006 to 2017 with cervical cancer in the California Cancer Registry. We linked this cohort to statewide ED discharge records to determine ED use and symptoms present at the encounter. Multivariable logistic regression models examined associations with ED use and multivariable Cox proportional hazards regression models examined associations with survival.ResultsOf the more than 16,000 women with cervical cancer in the study cohort, 28% presented symptomatically in the ED prior to diagnosis. Those presenting symptomatically were more likely to have public (odds ratio [OR] 1.16; 95% confidence interval [CI] 1.06-1.27) or no insurance (OR 4.81; CI 4.06-5.71) (vs. private), low socioeconomic status (SES) (OR 1.76; CI 1.52-2.04), late-stage disease (OR 5.29; CI 4.70-5.96), and had a 37% increased risk of death (CI 1.28-1.46).ConclusionNearly a third of women with cervical cancer presented symptomatically, outside of a primary care setting, suggesting that many women, especially those with low SES, may not be benefiting from screening or healthcare following abnormal results.